CubaseBio
the company is building technology that enables scalable, true 3D mapping of gene expression inside intact biological samples—moving beyond the limitations of traditional 2D tissue slices
CubaseBio has raised €5.9M across 1 funding round from 7 investors, most recently a round in Feb 2026. Based in Stockholm, Sweden; active in Healthtech. Data as of 28 Oct 2026.
Stockholm, Swedenwww.linkedin.com/company/cubasebio ↗
Total raised
€5.9M
€5,900,000
Funding rounds
1
Investors
7
distinct backers
Active since
2026-02
latest 2026-02
Funding by year
EUR raised per year · 2026 YTDCubaseBio — funding by year — interactive chart.
Data table
| CubaseBio — funding by year | |
|---|---|
| 2026 | €5.9M |
Signals
High confidenceRaise-next likelihood31
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-02-19 | Other | €5.9M | Almi Invest,Angel Investors,European Innovation Council,Illumina Ventures,Life Science Invest,Nordic Science Investments+1 more | View deal → |